PNEUMOCYSTIS CARINII; INFECTION, RESULTING FROM HIV DISEASE
Clinical trials for PNEUMOCYSTIS CARINII; INFECTION, RESULTING FROM HIV DISEASE explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCYSTIS CARINII; INFECTION, RESULTING FROM HIV DISEASE trials appear
Sign up with your email to follow new studies for PNEUMOCYSTIS CARINII; INFECTION, RESULTING FROM HIV DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial challenges 3-Week steroid rule for deadly pneumonia
Disease control Not yet recruitingThis study aims to find the best length of steroid treatment for adults with weakened immune systems who have a severe lung infection called PCP. It will compare stopping steroids after 10 days (if the patient has recovered enough) to the standard 21-day course. The goal is to se…
Matched conditions: PNEUMOCYSTIS CARINII; INFECTION, RESULTING FROM HIV DISEASE
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Doctors seek better options for dangerous lung infection when standard treatment fails
Disease control Not yet recruitingThis study aims to find the best alternative treatment for Pneumocystis pneumonia (PCP), a serious lung infection that affects people with weakened immune systems. When the standard antibiotic treatment can't be used due to allergies, side effects, or poor response, doctors curre…
Matched conditions: PNEUMOCYSTIS CARINII; INFECTION, RESULTING FROM HIV DISEASE
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC